CAS: 125-51-9; Pipenzolate Bromide

该化合物是一种主要用作抗胆碱基剂的四硝基铵化合物,其特点是能够抑制肌肉受体的乙酰胆碱化作用,从而有效地处理与过度唾液化和胃肠功能紊乱有关的各种条件;该物质似乎是白的,是白的,是晶状粉,在水中可溶解,便于其用于制药配方;其化学结构包括一种溴离子,有助于其药理特性; 平聚二甲酸盐往往以口服药片或可注射的溶液的形式施用; 与许多抗胆碱性制剂一样,它可能会造成副作用,如干口腔,模糊视力和内分泌对自导...

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号74-83-9 溴甲烷

合成工艺路线路线简述

    📜溴甲烷,Alkaline Earth Salt Of/the/ Methylsulfuric Acid置于乙醇体系中,化学反应生成溴哌喷酯
    参考文献:Antispasmodics. I. Substituted Acetic Acid Esters Of 1-Alkyl-3-Hydroxypiperidine1
    标题:Antispasmodics. I. Substituted Acetic Acid Esters Of 1-Alkyl-3-Hydroxypiperidine1
    摘要:
    Doi:10.1021/ja01126A039

    海关参考信息

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1080/15376510701857262
    摘要:Kruhlak NL, Choi SS, Contrera JF, Weaver JL, Willard JM, Hastings KL, Sancilio LF. Development of a Phospholipidosis Database and Predictive Quantitative Structure-Activity Relationship (QSAR) Models. Toxicology Mechanisms and Methods. 2008 Jan;18(2-3):217–27. doi: 10.1080/15376510701857262.
    参考文献:10.1038/ncb3255
    摘要:Lin R, Elf S, Shan C, Kang HB, Ji Q, Zhou L, Hitosugi T, Zhang L, Zhang S, Seo JH, Xie J, Tucker M, Gu TL, Sudderth J, Jiang L, Mitsche M, DeBerardinis RJ, Wu S, Li Y, Mao H, Chen PR, Wang D, Chen GZ, Hurwitz SJ, Lonial S, Arellano ML, Khoury HJ, Khuri FR, Lee BH, Lei Q, Brat DJ, Ye K, Boggon TJ, He C, Kang S, Fan J, Chen J. 6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling. Nat Cell Biol. 2015 Nov;17(11):1484–96.
    摘要:
    摘要:Compilation of LD50 Values of New Drugs.
    摘要:Journal of Pharmacology and Experimental Therapeutics., 112(64), 1954 []
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知